HK1004910A1 - Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients - Google Patents
Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patientsInfo
- Publication number
- HK1004910A1 HK1004910A1 HK98104022A HK98104022A HK1004910A1 HK 1004910 A1 HK1004910 A1 HK 1004910A1 HK 98104022 A HK98104022 A HK 98104022A HK 98104022 A HK98104022 A HK 98104022A HK 1004910 A1 HK1004910 A1 HK 1004910A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carnitine
- acyl
- aids
- carnitines
- related syndromes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920693A IT1258491B (it) | 1992-09-24 | 1992-09-24 | Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi. |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1004910A1 true HK1004910A1 (en) | 1998-12-11 |
Family
ID=11401203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98104022A HK1004910A1 (en) | 1992-09-24 | 1998-05-09 | Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients |
Country Status (12)
Country | Link |
---|---|
US (1) | US5631288A (xx) |
EP (1) | EP0590355B1 (xx) |
JP (1) | JPH06227983A (xx) |
KR (1) | KR0136559B1 (xx) |
AT (1) | ATE160090T1 (xx) |
DE (1) | DE69315162T2 (xx) |
DK (1) | DK0590355T3 (xx) |
ES (1) | ES2110551T3 (xx) |
GR (1) | GR3025372T3 (xx) |
HK (1) | HK1004910A1 (xx) |
IT (1) | IT1258491B (xx) |
ZA (1) | ZA936300B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6922994A (en) * | 1993-06-21 | 1995-01-17 | Bernardini, Attilio | Use of acylcarnitin to treat illnesses caused by aids |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
IT1291127B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
EP2134351B1 (en) | 2007-03-13 | 2016-04-27 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
CN109069532A (zh) | 2016-02-11 | 2018-12-21 | 营养21有限责任公司 | 含铬组合物用于改善健康和健身 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1143214B (it) * | 1981-07-09 | 1986-10-22 | Sigma Tau Ind Farmaceuti | Acil derivato della carnitina quale immunomodulatore |
IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
US5272153A (en) * | 1986-12-31 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
-
1992
- 1992-09-24 IT ITRM920693A patent/IT1258491B/it active IP Right Grant
-
1993
- 1993-08-27 ZA ZA936300A patent/ZA936300B/xx unknown
- 1993-09-06 EP EP93114235A patent/EP0590355B1/en not_active Expired - Lifetime
- 1993-09-06 DE DE69315162T patent/DE69315162T2/de not_active Expired - Lifetime
- 1993-09-06 ES ES93114235T patent/ES2110551T3/es not_active Expired - Lifetime
- 1993-09-06 AT AT93114235T patent/ATE160090T1/de active
- 1993-09-06 DK DK93114235.0T patent/DK0590355T3/da active
- 1993-09-13 KR KR1019930018520A patent/KR0136559B1/ko not_active IP Right Cessation
- 1993-09-24 JP JP5237790A patent/JPH06227983A/ja active Pending
-
1995
- 1995-01-09 US US08/370,357 patent/US5631288A/en not_active Expired - Lifetime
-
1997
- 1997-11-13 GR GR970402512T patent/GR3025372T3/el unknown
-
1998
- 1998-05-09 HK HK98104022A patent/HK1004910A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0590355T3 (da) | 1998-03-02 |
IT1258491B (it) | 1996-02-26 |
EP0590355B1 (en) | 1997-11-12 |
ZA936300B (en) | 1995-02-27 |
DE69315162D1 (de) | 1997-12-18 |
EP0590355A1 (en) | 1994-04-06 |
KR940006576A (ko) | 1994-04-25 |
ITRM920693A0 (it) | 1992-09-24 |
DE69315162T2 (de) | 1998-03-12 |
US5631288A (en) | 1997-05-20 |
KR0136559B1 (ko) | 1998-04-25 |
ES2110551T3 (es) | 1998-02-16 |
GR3025372T3 (en) | 1998-02-27 |
ATE160090T1 (de) | 1997-11-15 |
JPH06227983A (ja) | 1994-08-16 |
ITRM920693A1 (it) | 1994-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8712073D0 (en) | Medicament | |
IE870194L (en) | Use of lithium compounds in senile dementia | |
GB2285219B (en) | Use of norastemizole for the treatment of allergic disorders | |
GR3025372T3 (en) | Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients | |
EP0414772A4 (en) | Method for treating acne | |
ES2026304A6 (es) | Procedimiento de fabricacion de una forma de dosificacion de nicardipina. | |
DK0629400T3 (da) | Idebenon-holdige præparater til behandling af Alzheimer's syge | |
ZA895345B (en) | Therapeutic compounds | |
LU90791I2 (fr) | Potentialisateur d'effets antineoplasique et agent antineoplasique | |
AU670491C (en) | Pharmaceutical for the treatment of skin disorders | |
GB2162748B (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
HK61897A (en) | New derivatives of physostigmine their use and pharmaceutical formulations containing them | |
HK175896A (en) | Medicament for the treatment of cardiac insufficiency | |
EP0642338A1 (en) | USE OF (E) - 2 - (P -FLUOROPHENETHYL) - 3 - FLUOROALLYLAMINE FOR TREATING ALZHEIMER'S DISEASE. | |
GR3003880T3 (xx) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |